These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 21047224

  • 21. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
    Kotulska K, Borkowska J, Roszkowski M, Mandera M, Daszkiewicz P, Drabik K, Jurkiewicz E, Larysz-Brysz M, Nowak K, Grajkowska W, Domańska-Pakieła D, Jóźwiak S.
    Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
    [Abstract] [Full Text] [Related]

  • 22. Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus.
    Aguilera D, Flamini R, Mazewski C, Schniederjan M, Hayes L, Boydston W, Castellino RC, MacDonald TJ.
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e448-51. PubMed ID: 24276039
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
    Kingswood JC, Jozwiak S, Belousova ED, Frost MD, Kuperman RA, Bebin EM, Korf BR, Flamini JR, Kohrman MH, Sparagana SP, Wu JY, Brechenmacher T, Stein K, Berkowitz N, Bissler JJ, Franz DN.
    Nephrol Dial Transplant; 2014 Jun; 29(6):1203-10. PubMed ID: 24729041
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Everolimus and giant-cell astrocytomas in tuberous sclerosis.
    Jia J, Xiong L, Chen S.
    N Engl J Med; 2011 Feb 10; 364(6):577. PubMed ID: 21306252
    [No Abstract] [Full Text] [Related]

  • 27. Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma.
    Krueger DA, Care MM, Agricola K, Tudor C, Mays M, Franz DN.
    Neurology; 2013 Feb 05; 80(6):574-80. PubMed ID: 23325902
    [Abstract] [Full Text] [Related]

  • 28. The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma.
    Bissler JJ, Franz DN, Frost MD, Belousova E, Bebin EM, Sparagana S, Berkowitz N, Ridolfi A, Kingswood JC.
    Pediatr Nephrol; 2018 Jan 05; 33(1):101-109. PubMed ID: 28993887
    [Abstract] [Full Text] [Related]

  • 29. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
    Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ.
    Pediatr Neurol; 2013 Dec 05; 49(6):439-44. PubMed ID: 24138953
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex.
    Perek-Polnik M, Jóźwiak S, Jurkiewicz E, Perek D, Kotulska K.
    Eur J Paediatr Neurol; 2012 Jan 05; 16(1):83-5. PubMed ID: 22000822
    [Abstract] [Full Text] [Related]

  • 34. Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex.
    Yalon M, Ben-Sira L, Constantini S, Toren A.
    Childs Nerv Syst; 2011 Jan 05; 27(1):179-81. PubMed ID: 20703486
    [Abstract] [Full Text] [Related]

  • 35. Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.
    Prato G, Mancardi MM, Baglietto MG, Janis S, Vercellino N, Rossi A, Consales A, Raso A, Garrè ML.
    J Child Neurol; 2014 Sep 05; 29(9):NP54-7. PubMed ID: 24056156
    [Abstract] [Full Text] [Related]

  • 36. Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies.
    Franz DN, Budde K, Kingswood JC, Belousova E, Sparagana S, de Vries PJ, Berkowitz N, Ridolfi A, Bissler JJ.
    J Eur Acad Dermatol Venereol; 2018 Oct 05; 32(10):1796-1803. PubMed ID: 29569806
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.
    Skalicky AM, Rentz AM, Liu Z, Wheless JW, Pelletier CL, Dunn DW, Frost MD, Nakagawa J, Magestro M, Prestifilippo J, Pashos C.
    J Child Neurol; 2015 Apr 05; 30(5):563-9. PubMed ID: 24667738
    [Abstract] [Full Text] [Related]

  • 40. Everolimus and giant-cell astrocytomas in tuberous sclerosis.
    Nawashiro H, Shinomiya N.
    N Engl J Med; 2011 Feb 10; 364(6):576-7; author reply 577. PubMed ID: 21306253
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.